Dr Lisa Devine discusses the implications of a case-control study conducted in France that assessed the risk of intracranial meningioma associated with progestogen use.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.